Sun Pharmaceutical Industries makes generic and speciality medicines. Its tablets, injectables and creams treat long-term conditions such as heart disease, diabetes, skin disorders and mental illness, and they are sold in India, America and many emerging markets. Speciality brands include Ilumya, a psoriasis treatment. Dilip Shanghvi started the business in 1983 in Vapi, Gujarat, with a handful of psychiatry medicines, and later expanded through acquisitions including Ranbaxy Laboratories in 2015.
Sun Pharmaceutical Industries Limited is listed on the National Stock Exchange of India under the symbol SUNPHARMA (SUNPHARMA.NS on SwinGrowth). It is part of the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry, and is based in Mumbai, India.
This page opens SwinGrowth's analysis of Sun Pharmaceutical Industries from its real daily price history: an entry zone, a stop loss and two price targets for a swing trade, with its trend, RSI, moving averages, volume, support and resistance.
Other Healthcare stocks on SwinGrowth: UnitedHealth, Merck and AbbVie.
Education, not financial advice. SwinGrowth does not predict prices or tell you to buy or sell.